NSE:BAFNAPH

BAFNA PHARMACEUTICALS LTD

₹409.85
at close · 8 Oct 2026
▲ 8.00 (+1.99%)

Latest filings

  1. Trading Window Closed from Oct 1 Until Q2 FY27 Results Declaration · Compliance
  2. Bafna Pharma 31st AGM: All 3 resolutions passed with near-unanimous support · Board & Shareholder Meetings
  3. Bafna Pharma 31st AGM held; 3 ordinary resolutions transacted · Board & Shareholder Meetings
All filings ↓
Ask Nexa about BAFNA PHARMACEUTICALS LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

A listed company listed on NSE and BSE, reporting revenue of ₹42 Cr over the trailing twelve months.

Market Cap
₹970 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
-47.6%·
ROCE (FY20)
ROE -48.3% · margin -49.6%
Leverage
0.00·
Debt / Equity · low
Net cash ₹8.48 Cr
Moves on a normal day
2.00%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves

Scorecard

Measured from the filed financials · as of FY20 — not investment advice

Strengths
No borrowings on the balance sheet
Concerns
Negative returns on capital — −47.6%

Charts

How has the market priced it — with filings on the timeline?

BAFNAPH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from BAFNA PHARMACEUTICALS LTD's filed financials and exchange disclosures

What does BAFNA PHARMACEUTICALS LTD do?

BAFNA PHARMACEUTICALS LTD is listed on NSE and BSE, trading under the symbol BAFNAPH.

Is BAFNA PHARMACEUTICALS LTD profitable?

No. Over the trailing twelve months BAFNA PHARMACEUTICALS LTD reported a net loss of ₹25 Cr on revenue of ₹42 Cr.

Is BAFNA PHARMACEUTICALS LTD debt-free?

Yes. It reported no borrowings on its 31 Mar 2020 balance sheet, and ₹8.48 Cr of cash.

How much does the BAFNA PHARMACEUTICALS LTD share price move in a day?

On a typical session BAFNA PHARMACEUTICALS LTD moves 2.00% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

Where can I track BAFNA PHARMACEUTICALS LTD's announcements?

Every NSE and BSE filing by BAFNA PHARMACEUTICALS LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.